A longitudinal 5-year study for the prediction of HCC, death and liver decompensation by ARFI elastography

• Conditions: K74.0; Hepatic fibrosis

• Registration Number: DRKS00031824
• Lead Sponsor: Medizinische Klinik 1, Universitätsklinikum Erlangen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-03-31
• Study Start: 2023-05-08
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 335

Inclusion Criteria

Correct ARFI measurement (at least 5 measurements) of the right liver lobe, follow-up patient data of at least 5 years after ARFI measurement

Exclusion Criteria

Inadequate ARFI measurement, no complete follow-up data during the observation period

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
iver related survival

Secondary Outcome Measures

Name	Time	Method
Overall survival, occurrence of HCC, occurrence of liver decompensation/variceal bleeding